The Chemours Company (CC) — Fair Value Analysis

Base-case fair value (P50): $13.68 · Current price: $15.85 · Verdict: Fairly Valued

The Verdict on CC

Based on our proprietary Monte Carlo simulations, CHEMOURS (CC) is currently assessed as Fairly Valued. While the stock trades at $15.85, our median fair value (P50) stands at $13.68. This indicates an -13.7% gap, suggesting the market price is closely aligned with our probabilistic fair value estimate. Despite a "weak" quality tier reflecting operational and financial health challenges relative to its sector, CC's present trading level does not suggest significant overvaluation or undervaluation when considering the range of potential future outcomes modeled. Investors should note this alignment between the market and the P50 fair value.

How CC stacks up against peers

CHEMOURS's "weak" quality tier is a crucial factor in its overall assessment. This designation reflects operational and financial health metrics that trail its sector counterparts, signaling potential headwinds or structural disadvantages. While the Monte Carlo simulations integrate these fundamental aspects, arriving at a Fairly Valued verdict near $15.85 relative to the $13.68 fair value, the underlying "weak" quality tier remains a consideration. This suggests that while the stock isn't explicitly overvalued, its ability to generate substantial future upside, or its resilience in downside scenarios, may be constrained by these health indicators compared to stronger industry players.

What this means for investors

For investors considering CHEMOURS (CC), the "Fairly Valued" verdict from our Monte Carlo analysis implies that the current $15.85 is largely in line with its intrinsic value, as indicated by the $13.68 estimate. The -13.7% figure highlights this close alignment. While our simulations do explore both upside and downside scenarios, the "weak" quality tier introduces an element of caution, suggesting potential volatility or limited robustness in challenging market conditions. To fully grasp the probabilistic distribution of CC's future value, including specific bear-case (P10) and bull-case (P90) targets, sign up for a free FairCurve account. Track CC's fair value as new fundamentals are released.